Merck Quarterly Financial Report Q1_2010 - Merck shares (optimized for printing)

The Merck share price declined 7.9% during the first quarter to EUR 60.00 on March 31, 2010, from EUR 65.16 on December 30, 2009. The share price high during the first quarter was EUR 67.67, recorded on January 20. The low price for the quarter was EUR 57.62 on February 25. Germany’s DAX Index, of which Merck is a member, rose 3.3% during the first quarter and the Bloomberg Europe Pharmaceuticals Index fell 2.2%.

Share data¹

XLS

1^st quarter
2010

Year
2009

1	Share-price relevant figures relate to the closing price in XETRA trading on the Frankfurt Stock Exchange.
2	The calculation of the theoretical number of shares is based on the fact that the general partner‘s equity capital is not represented by shares. As the share capital of EUR 168.0 million was divided into 64.6 million shares, the corresponding calculation resulted in 152.8 million theoretical shares for the general partner’s capital of EUR 397.2 million on the balance sheet date March 31, 2010.
3	Based on the theoretical number of shares as of March 31, 2010.

Earnings per share after tax and non-controlling interest in EUR

0.88

1.68

Share price high in EUR

(Jan. 20) 67.67

(July 1) 74.37

Share price low in EUR

(Feb. 25) 57.62

(March 6) 57.24

Closing share price in EUR

(March 31) 60.00

(Dec. 30) 65.16

Actual number of shares in millions

64.6

Theoretical number² of shares in millions

217.4

Market capitalization³ in EUR million

13,034

14,165

Merck shares

The performance of Merck shares vs. the DAX®/Bloomberg Europe Pharmaceuticals Index